AnalystsSudan LoganathanSudan Loganathan's Stock Forecasts
AnalystsSudan Loganathan
Sectors:
Industries:
Analyst Ranking
Bottom 2%
#4927 out of 5017 analysts
Average Return
-15.61%
Win Rate
31%10 out of 32
Risk vs Reward
Poor
Good
Sudan Loganathan's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Delcath Systems IncDCTH | +116.27% | $7.07 | $15.29 | 2024-05-13 - 2025-05-13 | Strong Buy |
Adc Therapeutics SaADCT | +100.00% | $1.60 | $3.20 | 2025-02-24 - 2025-09-15 | Strong Buy |
Blueprint Medicines CorpBPMC | +46.33% | $87.20 | $127.60 | 2025-01-02 - 2025-06-03 | Strong Buy |
Delcath Systems IncDCTH | +33.00% | $7.91 | $10.52 | 2024-08-06 - 2025-08-05 | Strong Buy |
Ideaya Biosciences IncIDYA | +16.81% | $21.00 | $24.53 | 2025-02-14 - 2025-09-15 | Strong Buy |
Sudan Loganathan Analyst Color
Get additional color on Sudan Loganathan's coverage of popular stocks
Sudan Loganathan's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
C4 Therapeutics IncCCCC | 2 | Strong Buy | $6.00 | +68.07% | Upgrades | a day ago |
Ideaya Biosciences IncIDYA | 3 | Strong Buy | $45.00 | +83.45% | Reiterates | 7 days ago |
Nurix Therapeutics IncNRIX | 4 | Strong Buy | $30.00 | +246.02% | Reiterates | 2 months ago |
Exelixis IncEXEL | 5 | Strong Buy | $60.00 | +53.81% | Upgrades | 3 months ago |
Delcath Systems IncDCTH | 3 | Strong Buy | $25.00 | +134.30% | Reiterates | 3 months ago |
Blueprint Medicines CorpBPMC | 3 | Hold | $135.00 | +4.28% | Downgrades | 3 months ago |
Immunome IncIMNM | 2 | Strong Buy | $30.00 | +216.46% | Reiterates | 6 months ago |
Elevation Oncology IncELEV | 3 | Strong Buy | $5.00 | +1,269.86% | Reiterates | 6 months ago |
Catalyst Pharmaceuticals IncCPRX | 2 | Strong Buy | $33.00 | +67.00% | Reiterates | 7 months ago |
Adc Therapeutics SaADCT | 2 | Strong Buy | $8.00 | +150.00% | Maintains | 7 months ago |
Bicycle Therapeutics PLCBCYC | 2 | Hold | $15.00 | +118.66% | Reiterates | 8 months ago |
Kymera Therapeutics IncKYMR | 2 | Strong Buy | $60.00 | +26.90% | Reiterates | 8 months ago |
Actinium Pharmaceuticals IncATNM | 2 | Strong Buy | $5.00 | +208.64% | Reiterates | 10 months ago |
Arvinas IncARVN | 1 | Strong Buy | $55.00 | +610.59% | Initiates Coverage On | 10 months ago |
Pyxis Oncology IncPYXS | 1 | Strong Buy | $13.00 | +584.21% | Initiates Coverage On | 10 months ago |
Sensei Biotherapeutics IncSNSE | 2 | Strong Buy | $100.00 | N/A | Reiterates | a year ago |
Inovio Pharmaceuticals IncINO | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.